S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ASLN ASLAN Pharmaceuticals Ltd

0.4206

-0.0265 (-5.93%)

May 06 2024 - Closed

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

ASLAN Pharmaceuticals (NASDAQ:ASLN)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more ASLAN Pharmaceuticals Charts.

ASLAN Pharmaceuticals (NASDAQ:ASLN)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more ASLAN Pharmaceuticals Charts.

Aslan Pharmaceuticals Ltd News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 24 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 22 December 2023 (4 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 8 December 2023 (5 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 27 October 2023 (6 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 24 October 2023 (6 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 16 October 2023 (7 months ago) • Edgar (US Regulatory)

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
Friday 18 August 2023 (9 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 11 August 2023 (9 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 20 July 2023 (10 months ago) • Edgar (US Regulatory)

More Aslan Pharmaceuticals Ltd News Articles

Greene Concepts (PK)

Movement Industries (PK)

Kraig Biocraft Laborator... (QB)

Therapeutic Solutions (PK)

TheGlobe com (PK)

Elite Pharmaceuticals (QB)

Mullen Automotive

Digital Brand Media and ... (PK)

Innerscope Hearing Techn... (PK)

Alternet Systems (PK)

International Star (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions